.png)
.png)
Chief Medical Officer
Qpex Biopharma
Disclosure(s): Qpex Biopharma: Employee
Jeff Loutit, MBChB, is the Chief Medical Officer responsible for global clinical development, and medical and regulatory affairs, at Qpex Biopharma. He has over 20 years of experience in anti-infective and pulmonary drug development. Prior to Qpex, Jeff was Chief Medical Officer at Mpex, Rempex, and The Medicines Company where he was responsible for the global Phase 1 through 3 clinical development of inhaled levofloxacin, oritavancin, intravenous minocycline, and meropenem-vaborbactam. He received his medical training at Otago University in New Zealand. Following an Infectious Disease Fellowship at Stanford University, he joined the Infectious Disease faculty at Stanford and was Chief of Infectious Disease at the Palo Alto VA Hospital.